Tin tức & Cập nhật
Lọc theo Chuyên ngành:
East Asia tops global lung cancer incidence and mortality
East Asia topped the world’s incidence and mortality of lung cancer in 2020, according to a global study conducted by the Chinese University of Hong Kong (CUHK) and the Association of Pacific Rim Universities (APRU).
East Asia tops global lung cancer incidence and mortality
14 Feb 2022
Risk downgrade common in GGG3 prostate cancer patients with single positive biopsy core
In Gleason grade group (GGG) 3 prostate cancer patients with a single intermediate-risk positive biopsy core, risk downgrading appears to be more likely than upgrading, reports a new study.
Risk downgrade common in GGG3 prostate cancer patients with single positive biopsy core
13 Feb 2022
Recurrent node-positive breast cancer reveals distant metastasis in patients
Distant metastasis is present in all patients with node-positive breast cancer (NPBC) at the time of recurrence, reveals a study. Compared with diffusely metastatic (DM) patients, those with oligometastasis (OM) have shorter time to recurrence but longer overall survival (OS).
Recurrent node-positive breast cancer reveals distant metastasis in patients
12 Feb 2022
Which factor impels offering of postoperative chemotherapy in nonmuscle invasive bladder cancer?
A recent study has shown clear preferences by urologists when providing postoperative immediate chemotherapy in nonmuscle invasive bladder cancer (NMIBC). Factors beyond clinical variables, such as the structure of the recovery room, play a role in this decision-making process.
Which factor impels offering of postoperative chemotherapy in nonmuscle invasive bladder cancer?
11 Feb 2022
Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
The development of immune-related adverse events (irAEs) in non-Hodgkin lymphoma (NHL) patients treated with immune checkpoint inhibitors (ICI) may indicate better long-term survival, a recent study has found.
Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
11 Feb 2022
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
The risk of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) was substantially reduced among girls who were offered the bivalent human papillomavirus (HPV) vaccine, particularly those who were offered it at age 12–13 years, according to an observational study from England.